Overview

Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.

Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Lima association in the control of type 2 diabetes mellitus
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Dapagliflozin
Linagliptin